Unilever Investor Event Presentation Deck

Unilever Our growth model underpinned by disciplined capital allocation Operational investment Capex % turnover Covid impact 3.0 2.8 0.6 2.7 1.8 2017 18 19 20 21 0.9 2.4 Restructuring €bn 1.2 0.9 0.6 2017 18 19 20 21 Portfolio reshaping Acquisitions since 2017 €17bn invested dermalogica €11bn proceeds NUTRAFOL Disposals since 2017 tips PG Flora 17% of portfolio rotated Capital returns Cash dividends €bn 4.2 4.1 4.5 3.9 2017 18 19 20 21 Share buybacks €14bn 4.3 2017-21 up to €3bn 2022-23 18

View entire presentation